Sulforidazine
Sulforidazine is a type of antipsychotic medication used primarily in the treatment of schizophrenia. It belongs to the class of typical antipsychotics, also known as first-generation antipsychotics, which were the first group of drugs developed to treat psychotic disorders.
Pharmacology[edit]
Sulforidazine works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter, a type of chemical messenger that transmits signals in the brain and other areas of the body. By blocking these receptors, sulforidazine helps to balance the levels of dopamine and other neurotransmitters in the brain, which can help to reduce symptoms of schizophrenia.
Uses[edit]
Sulforidazine is primarily used to treat schizophrenia, a mental disorder characterized by abnormal social behavior and failure to understand reality. It can help to reduce symptoms such as hallucinations, delusions, and disorganized thinking. In some cases, it may also be used to treat other mental health conditions, as determined by a healthcare provider.
Side Effects[edit]
Like all medications, sulforidazine can cause side effects. Common side effects can include drowsiness, dizziness, and dry mouth. More serious side effects can include movement disorders, such as tardive dyskinesia, and cardiovascular effects, such as irregular heart rhythms. It is important for individuals taking sulforidazine to be closely monitored by their healthcare provider to manage any potential side effects.
History[edit]
Sulforidazine was first developed in the 1960s as part of the first generation of antipsychotic medications. It was widely used for several decades, but its use has declined in recent years due to the development of newer, second-generation antipsychotics, which are generally associated with fewer side effects.
See Also[edit]
- Sulforidazine
-
Chemical structure of Sulforidazine
-
3D model of Sulforidazine
-
Synthesis pathway of Sulforidazine
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
